0001686266-18-000009.txt : 20180713
0001686266-18-000009.hdr.sgml : 20180713
20180713130605
ACCESSION NUMBER: 0001686266-18-000009
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20180713
DATE AS OF CHANGE: 20180713
EFFECTIVENESS DATE: 20180713
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: ReShape Lifesciences Inc.
CENTRAL INDEX KEY: 0001371217
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 481293684
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0131
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-316826
FILM NUMBER: 18952130
BUSINESS ADDRESS:
STREET 1: 1001 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92673
BUSINESS PHONE: 9494296680
MAIL ADDRESS:
STREET 1: 1001 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92673
FORMER COMPANY:
FORMER CONFORMED NAME: EnteroMedics Inc
DATE OF NAME CHANGE: 20060802
D
1
primary_doc.xml
X0708
D
LIVE
0001371217
ReShape Lifesciences Inc.
1001 CALLE AMANECER
SAN CLEMENTE
CA
CALIFORNIA
92673
9494296680
DELAWARE
EnteroMedics Inc
Corporation
true
Dan
Gladney
1001 CALLE AMANECER
San Clemente
CA
CALIFORNIA
92673
Executive Officer
Director
Scott
Youngstrom
1001 CALLE AMANECER
San Clemente
CA
CALIFORNIA
92673
Executive Officer
Gary
Blackford
1001 CALLE AMANECER
San Clemente
CA
CALIFORNIA
92673
Director
Jon
Tremmel
1001 CALLE AMANECER
San Clemente
CA
CALIFORNIA
92673
Director
Lori
McDougal
1001 CALLE AMANECER
San Clemente
CA
CALIFORNIA
92673
Director
Other Health Care
Decline to Disclose
- 06b
false
2018-07-10
false
true
true
false
0
H.C. Wainwright & Co., LLC
375
None
None
430 Park Avenue
New York
NY
NEW YORK
10022
FL
FLORIDA
NJ
NEW JERSEY
NY
NEW YORK
TX
TEXAS
false
2793520
2793520
0
The warrants and underlying shares of common stock include warrants (i) to purchase 1,241,382 shares of common stock issued to certain institutional investors and (ii) to purchase 86,897 shares of common stock to H.C. Wainwright ("HCW Warrants").
false
5
12414
0
H.C. Wainwright received the above sales commission in connection with the private placement of warrants. The HCW Warrants were issued to H.C. Wainwright in connection with a registered direct offering by the Company, which is not reported on this Form D.
0
false
ReShape Lifesciences Inc.
/s/ Scott Youngstrom
Scott Youngstrom
CFO
2018-07-13